Phenotypic expression of recurrent disease after liver transplantation: Minireview

American Journal of Transplantation

Volumn 10, Issue 5, 2010, Pages 1149-1154

  O'Grady, J G ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

HLA matching; Immunosuppression; Liver transplantation; Phenotype; Recurrent disease

Indexed keywords

ANTIVIRUS AGENT; CYCLOSPORIN; HEPATITIS B ANTIBODY; HLA ANTIGEN; IMMUNOSUPPRESSIVE AGENT; INTERFERON; PREDNISOLONE; RAPAMYCIN; TACROLIMUS; VIRUS PROTEIN;

AUTOIMMUNE HEPATITIS; CHOLESTATIC HEPATITIS; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS C; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; PHENOTYPE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RECURRENT DISEASE; SHORT SURVEY;

AUTOIMMUNE DISEASES; CHRONIC DISEASE; GRAFT SURVIVAL; HEPATITIS B; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; LIVER TRANSPLANTATION; PHENOTYPE; RECURRENCE;

EID: 77951235110     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03080.x     Document Type: Short Survey

References (33)

1. O'Grady JG, Smith HM, Davies SE et al. Hepatitis B reinfection after orthotopic liver transplantation: Serological and clinical implications. J Hepatol 1992 14 : 104 111
2. Davies SE, Portmann BC, O'Grady JG et al. Hepatic histological findings after transplantation for chronic hepatitis B, uncluding a unique pattern of fibrosing cholestatic hepatitis. Hepatology 1991 13 : 150 157.
3. Lau JY, Bain VG, Davies SE, et al. High level expression of hepatitis B viral antigens in fibrosing cholestatic hepatitis. Gastroenterology 1992 120 : 956 962.
4. Berenguer M. What determines the natural history of recurrent hepatitis C after liver transplantation. J Hepatol 2005 42 : 448 449. (Pubitemid 40342920)
5. McCashland T, Watt K, Lyden E et al. Retransplantation for hepatitis C: Results of a U.S. multicenter retransplant study. Liver transpl 2007 13 : 1246 1253. (Pubitemid 47457051)
6. Gopal DV, Rosen HR. Duration of antiviral therapy for cholestatic recurrence may need to be indefinite. Liver Transpl 2003 9 : 348 353.
7. Gane EJ, Roberts SK, Stedman CA et al. Combination therapy with a nucleoside polymerase (R7128) and protease (R7227/ITM-191) inhibitor in HCV: Safety, pharmacokinetics, and virological results from INFORM-1. (Abstract) Hepatology 2009 50 : 394A.
8. Kamar N, Ribes D, Izopet J, Rostaing L. Treatment of hepatitis C virus infection (HCV) after renal transplantation: Implications for HCV-positive dialysis patients awaiting a kidney transplant. Transplantation 2006 82 : 853 856. (Pubitemid 44564028)
9. Heinbach JK. Successful liver transplantation for hilar cholangiocarcinoma. Curr Opin Gastroenterol 2008 24 : 384 388. (Pubitemid 351535899)
10. Roayaie S, Schwartz JD, Sung MW et al. Recurrence of hepatocellular carcinoma after liver transplantation: Patterns and prognosis. Liver Transpl 2004 10 : 534 540. (Pubitemid 38443593)
11. Toso C, Meeberg GA, Bigam DL et al. De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: Long-term outcomes and side-effects. Transplantation 2007 83 : 1162 1168. (Pubitemid 46743675)
12. Neuberger J, Portmann B, Macdougall BR, Calne RY, Williams R. Recurrence of primary biliary cirrhosis after liver transplantation. N Engl j Med 1982 306 : 1 4. (Pubitemid 12194228)
13. Jacob DA, Neumann UP, Bahra M et al. Long-term follow-up after recurrence of primary biliary cirrhosis after liver transplantation in 100 patients. Clinical Transpl 2006 20 : 211 220.
14. Campsen J, Zimmerman M, Trotter J et al. Liver transplantation for primary biliary cirrhosis: Results of aggressive corticosteroid withdrawal. Trans Proc 2009 41 : 1707 1712.
15. Neuberger J, Gunson B, Hubscher S, Nightingale P. Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation. Liver Transpl 2004 10 : 488 489. (Pubitemid 38443587)
16. Sylvestre PB, Batta KP, Burgart LJ, Poterucha JJ, Wiesner RH. Recurrence of primary biliary cirrhosis after liver transplantation: Histologic estimate of incidence and natural history. Liver Transpl 2003 9 : 1086 1093. (Pubitemid 37304465)
17. Rowe IA, Webb K, Gunson, BK, Metha N, Haque S, Neuberger J. The impact of disease recurrence following liver transplantation: A single centre experience. Transpl Int 2008 21 : 459 465 (Pubitemid 351490169)
18. Gonzalez-Koch P, Czaja AJ, Carpenter HA et al. Recurrent auto-immune hepatitis after orthotopic liver transplantation. Liver Transpl 2001 7 : 302 310. (Pubitemid 32331533)
19. Vogel A, Heinrich E, Bahr MJ et al. Long-term outcome in liver transplantation for auto-immune hepatitis. Clin Transpl 2004 18 : 62 69. (Pubitemid 38195546)
20. Tripathi D, Neuberger J. Auto-immune hepatitis and liver transplantation: Indications, results, and management of recurrent disease. Sem Liv Dis 2009 29 : 286 296.
21. Heneghan MA, Portmann BC, Norris SM et al. Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults. Hepatology 2001 34 : 464 470. (Pubitemid 32791325)
22. Sheng R, Zajko AB, Campbell WL, Abu-Elmgagd K. Biliary strictures in hepatic transplants: Prevalence and types in patients with primary sclerosing cholangitis vs those with other liver diseases. Am J Roentgenol 1993 161 : 297 300. (Pubitemid 23224791)
23. Campsen J, Zimmerman MA, Trotter JF et al. Clinically recurrent primary sclerosing cholangitis following liver transplantation. Liver Transplant 2008 14 : 130 132. (Pubitemid 351267274)
24. Kugelmas M, Spiegelman P, Osgood MJ et al. Different immunosuppressive regimens and recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2003 9 : 727 732. (Pubitemid 36874461)
25. Kashyop R, Mantry P, Sharma R, Maloo MK, Safadjou I, Qi Y. Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis. J Gastroenterol Surg 2009 13 : 1480 1486.
26. Alabraba E, Nightingale P, Gunson B et al. A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts. Liver trans 2009 15 : 330 340.
27. Ong J, Younossi ZM, Reddy V et al. Cryptogenic cirrhosis and post-transplantation non-alcoholic liver disease. Liver Transpl 2001 7 : 797 801. (Pubitemid 32851301)
28. Ayata G, Gordon FD, Lewis WD et al. Cryptogenic cirrhosis: Clinicopathological findings at and after liver transplantation. Human Pathology 2002 33 : 1098 1104. (Pubitemid 35416707)
29. Devlin J, Doherty D, Thomson L et al. Defining the outcome of immunosuppression withdrawal after liver transplantation. Hepatology 1998 27 : 926 933. (Pubitemid 28160476)
30. Tisone G, Orlando G, Cardillo A et al. Complete weaning off immunosuppression is feasible in HCV liver transplant recipients and favourably impacts on the progression of disease recurrence. J Hepatol 2006 44 : 702 709.
31. Levitsky J, Hart J, Cohen SM, Te HS. The effect of immunosuppression on the recurrence of primary biliary cirrhosis after liver transplantation. Liver Transpl 2003 9 : 733 736. (Pubitemid 36874462)
32. Balan V, Ruppert K, Demetris J et al. Long-term outcome of human leukocyte antigen mismatching: Results of the National Institute of diabetes and digestive and Kidney Diseases liver transplantation database. Hepatology 2008 48 : 878 888.
33. Wright TL, Bou-Abboud C, Hassanein T et al. Disease recurrence following liver transplantation for autoimmune chronic active liver disease. Transplantation 1992 53 : 136 139.